secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001824293-25-000042
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio announces 1-for-17 reverse stock split effective Feb 21, 2025
---------------------------------------------------------------------

- Reverse split at 1:17 ratio, effective 4:01 p.m. ET on Feb 21, 2025; post-split trading begins Feb 24, 2025 on Nasdaq under symbol GRI.
- Outstanding shares will decrease from ~8.93 million to ~525,492; authorized share count unchanged.
- Reverse split is intended to regain compliance with Nasdaq minimum bid price requirement.
- Proportional adjustments will be made to exercise prices and shares for stock options, warrants, and convertible securities.
- No fractional shares issued; cash payment in lieu based on closing price on Feb 21, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000042/0001824293-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000042/val-20250219.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer